doTERRA Research Shows Potency and Efficacy of Essential Oils


doTERRA, the world leader in sourcing, testing, manufacturing and distribution of CPTG® essential oils, today announced the publication of 13 research studies by scientific experts at doTERRA. Each of the comprehensive research studies focuses on one or more essential oil and unveils important information about the efficacy and potency of these essential oils. doTERRA’s science team continuously conducts research to remain at the forefront of essential oil science and to ensure Wellness Advocates and consumers receive the highest-quality, therapeutic-grade essential oils in the world.

doTERRA’s science team includes more than 30 accomplished scientific experts and medical and scientific advisory panels. doTERRA remains committed to quality and is responsible for breakthroughs in evolving models of essential oil use, validation of use and state-of-the-art testing procedures.

“doTERRA’s mission hinges on discovering and developing the world’s most potent and effective essential oils,” said Dr. David Hill, doTERRA founding executive and chief medical officer. “These studies are a demonstration of our leadership in essential oil scientific advances, as well as our commitment to ensuring safe and powerful outcomes for families and individuals using doTERRA essential oils.”

The newly published papers include studies on:

  • Arborvitae
  • Bergamot
  • Cardamom
  • Cinnamon
  • Clove
  • Deep Blue, Rosemary, Wild Orange
  • Frankincense
  • Juniper Berry
  • Lemongrass
  • Melaleuca
  • Oregano
  • Vetiver
  • DDR Prime

In addition to doTERRA’s expert scientific staff, many of doTERRA’s experimental and clinical studies are performed in collaboration with world-class external partner laboratories and clinics carefully chosen according to expertise. doTERRA also supports many clinics and universities conducting studies in the field of essential oils and related natural products research. doTERRA is committed to engaging in ongoing research with a promise of full transparency in its findings.

For more information about doTERRA’s research, visit